These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23448469)

  • 1. Targeted radiosensitization in prostate cancer.
    Ghotra VP; Geldof AA; Danen EH
    Curr Pharm Des; 2013; 19(15):2819-28. PubMed ID: 23448469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecularly targeted radiosensitization chances towards gene aberration-due organ confined/regionally advanced prostate cancer radioresistance.
    Alberti C
    G Chir; 2015; 36(3):133-6. PubMed ID: 26188759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer: radioresistance molecular target-related markers and foreseeable modalities of radiosensitization.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2275-82. PubMed ID: 25219826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo.
    Mendonca MS; Turchan WT; Alpuche ME; Watson CN; Estabrook NC; Chin-Sinex H; Shapiro JB; Imasuen-Williams IE; Rangel G; Gilley DP; Huda N; Crooks PA; Shapiro RH
    Free Radic Biol Med; 2017 Nov; 112():318-326. PubMed ID: 28782644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation.
    Valerie NC; Casarez EV; Dasilva JO; Dunlap-Brown ME; Parsons SJ; Amorino GP; Dziegielewski J
    Cancer Res; 2011 Nov; 71(21):6817-26. PubMed ID: 21903767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
    Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
    BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.
    Chang L; Graham PH; Hao J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):469-96. PubMed ID: 24445654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.
    Xu L; Yang D; Wang S; Tang W; Liu M; Davis M; Chen J; Rae JM; Lawrence T; Lippman ME
    Mol Cancer Ther; 2005 Feb; 4(2):197-205. PubMed ID: 15713891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.
    Chang L; Graham PH; Ni J; Hao J; Bucci J; Cozzi PJ; Li Y
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):507-17. PubMed ID: 26253360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
    Xu C; Shen G; Chen C; Gélinas C; Kong AN
    Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells.
    Zhang Y; Xu Z; Ding J; Tan C; Hu W; Li Y; Huang W; Xu Y
    J Exp Clin Cancer Res; 2018 Jul; 37(1):174. PubMed ID: 30053873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
    Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C
    Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway.
    Chuang HY; Lee YP; Lin WC; Lin YH; Hwang JJ
    Sci Rep; 2019 Sep; 9(1):13284. PubMed ID: 31527721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells.
    Isebaert SF; Swinnen JV; McBride WH; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer.
    Mackey TJ; Borkowski A; Amin P; Jacobs SC; Kyprianou N
    Urology; 1998 Dec; 52(6):1085-90. PubMed ID: 9836559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment.
    Akagunduz O; Karaca B; Atmaca H; Uzunoglu S; Karabulut B; Sanli UA; Haydaroglu A; Uslu R
    J BUON; 2010; 15(4):763-7. PubMed ID: 21229643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway.
    Lee IY; Lin YY; Yang YH; Lin YS; Lin CL; Lin WY; Cheng YC; Shu LH; Wu CY
    BMC Pharmacol Toxicol; 2018 Jan; 19(1):5. PubMed ID: 29386061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.